AIMS: To investigate the expression of matrix metalloproteinase (MMP)-2, MMP-9, and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer (NMSC) and to compare their expression between different tumour types and with clinicopathological factors. METHODS AND RESULTS: A study of 11 normal skin, 29 Bowen's disease (BD), 40 squamous cell carcinoma (SCC) and 38 basal cell carcinoma (BCC) samples for MMP-2, MMP-9, TIMP-1 and TIMP-2 expression was carried out using immunohistochemistry and in situ hybridization. The expression of all metalloproteinases was greater in tumours than in normal skin. MMP-2 and MMP-9 expression was more extensive in the stroma of SCC than of BCC or BD. TIMP-1 expression was greater in the stroma of BCC than of SCC or BD and TIMP-2 expression was greater in the stroma of SCC than of BD. There was a correlation between increased metalloproteinase expression and depth of lesion (MMP-2 and TIMP-2), inflammation (MMP-2, MMP-9, TIMP-1 and TIMP-2) and microvessel density (MMP-2, MMP-9 and TIMP-2). CONCLUSIONS: MMP-2, MMP-9, TIMP-1 and TIMP-2 play an important role in the pathogenesis of non-melanoma skin cancer, but differ significantly in their expression levels between the tumour types examined. The immunoexpression of these proteins may be useful indicators of cutaneous cancer invasion and progression.
AIMS: To investigate the expression of matrix metalloproteinase (MMP)-2, MMP-9, and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer (NMSC) and to compare their expression between different tumour types and with clinicopathological factors. METHODS AND RESULTS: A study of 11 normal skin, 29 Bowen's disease (BD), 40 squamous cell carcinoma (SCC) and 38 basal cell carcinoma (BCC) samples for MMP-2, MMP-9, TIMP-1 and TIMP-2 expression was carried out using immunohistochemistry and in situ hybridization. The expression of all metalloproteinases was greater in tumours than in normal skin. MMP-2 and MMP-9 expression was more extensive in the stroma of SCC than of BCC or BD. TIMP-1 expression was greater in the stroma of BCC than of SCC or BD and TIMP-2 expression was greater in the stroma of SCC than of BD. There was a correlation between increased metalloproteinase expression and depth of lesion (MMP-2 and TIMP-2), inflammation (MMP-2, MMP-9, TIMP-1 and TIMP-2) and microvessel density (MMP-2, MMP-9 and TIMP-2). CONCLUSIONS:MMP-2, MMP-9, TIMP-1 and TIMP-2 play an important role in the pathogenesis of non-melanoma skin cancer, but differ significantly in their expression levels between the tumour types examined. The immunoexpression of these proteins may be useful indicators of cutaneous cancer invasion and progression.
Authors: Ivana Manola; Ana Mataic; Daniela Ledic Drvar; Ivan Pezelj; Tihana Regovic Dzombeta; Bozo Kruslin Journal: In Vivo Date: 2020 May-Jun Impact factor: 2.155
Authors: Alka Mahale; Hind Alkatan; Saeed Alwadani; Maha Othman; Maria J Suarez; Antoinette Price; Hailah Al-Hussain; Sabah Jastaneiah; Wayne Yu; Azza Maktabi; Edward P Deepak; Charles G Eberhart; Laura Asnaghi Journal: Mod Pathol Date: 2016-02-26 Impact factor: 7.842
Authors: Yao-Ping Lu; You-Rong Lou; Jamie J Bernard; Qing-Yun Peng; Tao Li; Yong Lin; Weichung Joe Shih; Paul Nghiem; Sue Shapses; George C Wagner; Allan H Conney Journal: Proc Natl Acad Sci U S A Date: 2012-05-21 Impact factor: 11.205
Authors: Yourong Lou; Qingyun Peng; Tao Li; Bonnie Nolan; Jamie J Bernard; George C Wagner; Yong Lin; Weichung Joe Shih; Allan H Conney; Yaoping Lu Journal: Nutr Cancer Date: 2013-09-26 Impact factor: 2.900
Authors: Lawrence Fitzgerald Kuklinski; Michael Scot Zens; Ann E Perry; Adele C Green; Margaret R Karagas Journal: Photodermatol Photoimmunol Photomed Date: 2017-01-17 Impact factor: 3.135
Authors: You-Rong Lou; Qing-Yun Peng; Tao Li; Christopher M Medvecky; Yong Lin; Weichung Joe Shih; Allan H Conney; Sue Shapses; George C Wagner; Yao-Ping Lu Journal: Carcinogenesis Date: 2011-04-27 Impact factor: 4.944